manufacturing
Europe’s CMO market set to double by 2018, says F&S
May 30, 2012Manufacturing and Production CMO, Europe, F&S, R&D, Taylor, manufacturing
The European market for pharmaceutical contract manufacturing will double from a value of around $10 billion last year to almost …
Onyx appoints Brian Jolly to commercial team
May 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing
Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …
EMA backs MabThera despite contamination issue
May 29, 2012Manufacturing and Production EMA, MabThera, Phil Taylor, Roche, manufacturing
The European Medicines Agency has completed a safety review of Roche’s MabThera convened after bacterial contamination was discovered in bioreactors …
Merck extends biocatalysis collaboration with Codexis
May 29, 2012Manufacturing and Production Codexis, Merck, Phil Taylor, Victrelis, manufacturing
Biocatalyst specialist Codexis has signed a three-year extension of its catalyst and process development collaboration with Merck to develop enzymes …
Genentech taken to task over Avastin production
May 15, 2012Manufacturing and Production Genentech, Phil Taylor, avastin, manufacturing
FDA inspections of a manufacturing facility for Roche/Genentech’s cancer drug Avastin (bevacizumab) uncovered a number of deficiencies which could increase …
Patheon starts winding down Swindon operations
May 10, 2012Manufacturing and Production CMO, Patheon, Swindon, manufacturing
North American contract manufacturer Patheon is winding down some operations at its facility in Swindon, UK, with the aim of …
BASF to build plant in US
May 8, 2012Manufacturing and Production BASF, Taylor, manufacturing, production
BASF has said it plans to build a new manufacturing facility for formic acid at its production site in Louisiana, …
Novartis will restart production at Lincoln plant in May
May 1, 2012Manufacturing and Production FDA, GMP, Lincoln, Nebraska, Novartis, manufacturing
Novartis chief executive Joe Jimenez has said that production at the firm’s troubled consumer health plant in Lincoln, Nebraska, will …
FDA approves greener process for Januvia production
May 1, 2012Manufacturing and Production Codexis, FDA, Januvia, Merck, manufacturing
The US Food and Drug Administration (FDA) has approved a new, more environmentally-friendly manufacturing process for Merck & Co’s diabetes …
Baxter planning $1 billion plasma facility for Atlanta
April 24, 2012Manufacturing and Production Atlanta, baxter, manufacturing, production
Baxter International has unveiled plans to build a major new manufacturing complex for its plasma-based therapies in Atlanta in the …
China bans medicines formulated in toxic capsules
April 17, 2012Manufacturing and Production China, SFDA, impurities, manufacturing
China’s State Food and Drug Administration (SFDA) has banned the sale of 13 medicines thought to be manufactured using contaminated …
Codexis and Merck develop green Victrelis production
April 10, 2012Manufacturing and Production Codexis, Merck, manufacturing
Merck has teamed up with catalyst specialist Codexis to develop a more efficient manufacturing process for recently-approved hepatitis C treatment …
Drugmakers ‘premature’ in requests for metal impurity data
April 5, 2012Manufacturing and Production ICH, manufacturing, metal impurity
Pharmaceutical manufacturers are acting ‘prematurely’ when asking excipient suppliers to provide metal impurity levels, according to a new position paper …
Novasep expands in China, raises €40m for investments
April 3, 2012Manufacturing and Production China, Novasep, Shanghai, manufacturing
French processing equipment supplier Novasep has opened a new facility in China to meet what it says is increasing demand …
Novartis to construct pharma plant in Turkey
April 2, 2012Manufacturing and Production Novartis, Turkey, manufacturing
Novartis has selected Turkey as its headquarters for central Asia, the Middle East and Africa and intends to set up …
Latest content
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
